Distribution of metastatic sites in renal cell carcinoma: A population-based analysis

Annals of Oncology

Volumn 23, Issue 4, 2012, Pages 973-980

  Bianchi, M ^a,b   Sun, M ^b   Jeldres, C ^b   Shariat, S F ^c   Trinh, Q D ^b,d   Briganti, A ^a   Tian, Z ^b   Schmitges, J ^b,e   Graefen, M ^e   Perrotte, P ^b   Menon, M ^d   Montorsi, F ^a   Karakiewicz, P I ^b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Bone metastases; Brain metastases; Metastatic disease; Renal cell carcinoma; Young age

Indexed keywords

ABDOMINAL CANCER; ADRENAL METASTASIS; ADULT; AGE DETERMINATION; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER INCIDENCE; CANCER LOCALIZATION; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; POPULATION RESEARCH; PRIORITY JOURNAL; THORAX CANCER;

AGE FACTORS; AGED; BONE NEOPLASMS; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; HUMANS; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 84859504806     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr362     Document Type: Article

References (26)

1. Bharat A, Aft RL, Gao F, Margenthaler JA. Patient and tumor characteristics associated with increased mortality in young women (≤40 years) with breast cancer. J Surg Oncol 2009; 100: 248-251.
2. Derwinger K, Kodeda K, Gerjy R. Age aspects of demography, pathology and survival assessment in colorectal cancer. Anticancer Res 2010; 30: 5227-5231.
3. Nakamura R, Saikawa Y, Takahashi T et al. Retrospective analysis of prognostic outcome of gastric cancer in young patients. Int J Clin Oncol 2011; [Epub ahead of print].
4. Sá nchez-Ortiz RF, Rosser CJ, Madsen LT et al. Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma. J Urol 2004; 171: 2160-2165.
5. Argani P, Olgac S, Tickoo SK et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol 2007; 31: 1149-1160.
6. Meyer PN, Clark JI, Flanigan RC, Picken MM. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am J Clin Pathol 2007; 128: 70-79.
7. Skolarus TA, Serrano MF, Berger DA et al. The distribution of histological subtypes of renal tumors by decade of life using the 2004 WHO classification. J Urol 2008; 179: 439-444.
8. Gillett MD, Cheville JC, Karnes RJ et al. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J Urol 2005; 173: 1893-1896.
9. Verhoest G, Veillard D, Guillé F et al. Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol 2007; 51: 1298-1305.
10. Culine S, Bekradda M, Kramar A et al. Prognostic factors for survival in patients with brain metastases from renal cell carcinoma. Cancer 1998; 83: 2548-2553.
11. Kume H, Kakutani S, Yamada Y et al. Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors? J Urol 2011; 185: 1611-1614.
12. Healthcare Cost and Utilization Project (HCUP). HCUP Quality Control Procedures. September 2008. Agency for Healthcare Research and Quality, Rockville, MD. www.hcup-us.ahrq.gov/db/quality.jsp (9 August 2011, date last accessed).
13. Whalen D, Houchens R, Elixhauser A. Final 2000 NIS Comparison Report. 2003. HCUP Methods Series Report #2003-1. U.S. Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/db/nation/nis/reports/NIS_Comparison_Report_2000.pdf (9 August 2011, date last accessed).
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
15. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992; 45: 613-619.
16. Beuselinck B, Oudard S, Rixe O et al. Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. Ann Oncol 2011; 22: 794-800.
17. Griffin N, Gore ME, Sohaib SA. Imaging in metastatic renal cell carcinoma. Am J Roentgenol 2007; 189: 360-370.
18. Schlesinger-Raab A, Treiber U, Zaak D et al. Metastatic renal cell carcinoma: results of a population-based study with 25 years follow-up. Eur J Cancer 2008; 44: 2485-2495.
19. Ljungberg B, Alamdari FI, Rasmuson T, Roos G. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 1999; 84: 405-411.
20. Sheehan JP, Sun M-H, Kondziolka D et al. Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 2003; 98: 342-349.
21. Woodward E, Jagdev S, McParland L et al. Skeletal complications and survival in renal cancer patients with bone metastases. Bone 2011; 48: 160-166.
22. Zekri J, Ahmed N, Coleman R, Hancock B. The skeletal metastatic complications of renal cell carcinoma. Int J Oncol 2001; 19: 379-382.
23. Rosen LS, Gordon D, Tchekmedyian S et al. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial-the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol 2003; 21: 3150-3157.
24. Lipton A, Zheng M, Seaman J. Zoledronic acid delays the onset of skeletalrelated events and progression of skeletal disease in patients with advanced renal cell carcinoma. Cancer 2003; 98: 962-969.
25. Reichel LM, Pohar S, Heiner J et al. Radiotherapy to bone has utility in multifocal metastatic renal carcinoma. Clin Orthop Relat Res 2007; 459: 133-138. doi:110.1097/BLO.1090b1013e3180616594.
26. Shuch B, La Rochelle JC, Klatte T et al. Brain metastasis from renal cell carcinoma. Cancer 2008; 113: 1641-1648.